202 related articles for article (PubMed ID: 6129139)
1. Clinical pharmacology of a new beta-adrenoceptor blocking drug, befunolol. Cross-over comparison with propranolol on repeated administration.
Ebihara A; Tawara K; Oka T; Ofuji T; Kawahara K
Eur J Clin Pharmacol; 1982; 23(3):189-95. PubMed ID: 6129139
[TBL] [Abstract][Full Text] [Related]
2. Effects of oral befunolol on heart rate and systolic blood pressure during submaximal exercise in man.
Miki N; Furusho Y; Itaya K; Midorikawa K; Kumagai E; Terasawa M; Ihara S; Matoba T; Toshima H
Jpn Circ J; 1980 Oct; 44(10):783-93. PubMed ID: 6107392
[TBL] [Abstract][Full Text] [Related]
3. Comparative beta-adrenoceptor blocking effect and pharmacokinetics of bucindolol and propranolol in man.
Maury M; Berdeaux A; Kher A; Duhaze P; Giudicelli JF
Eur J Clin Pharmacol; 1985; 27(6):649-56. PubMed ID: 2859199
[TBL] [Abstract][Full Text] [Related]
4. Comparative beta-adrenoceptor blocking effects and pharmacokinetics of penbutolol and propranolol in man.
Giudicelli JF; Richer C; Chauvin M; Idrissi N; Berdeaux A
Br J Clin Pharmacol; 1977 Apr; 4(2):135-40. PubMed ID: 16632
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic and pharmacodynamic interactions between nifedipine and propranolol or betaxolol.
Vinceneux P; Canal M; Domart Y; Roux A; Cascio B; Orofiamma B; Larribaud J; Flouvat B; Carbon C
Int J Clin Pharmacol Ther Toxicol; 1986 Mar; 24(3):153-8. PubMed ID: 2870990
[TBL] [Abstract][Full Text] [Related]
6. Pharmacodynamic and pharmacokinetic studies on prizidilol and nipradilol (K-351), antihypertensive drugs with combined vasodilator and beta-adrenoceptor blocking actions, in rabbits.
Kawashima K; Watanabe TX; Sokabe H
Jpn J Pharmacol; 1984 Dec; 36(4):519-26. PubMed ID: 6151998
[TBL] [Abstract][Full Text] [Related]
7. Comparative potency of intravenous penbutolol and propranolol in man.
Sharma PL; Sapru RP
Int J Clin Pharmacol Biopharm; 1978 Feb; 16(2):83-5. PubMed ID: 24597
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the haemodynamic effects of bucindolol, propranolol and pindolol in healthy volunteers.
O'Connor PC; Finch MJ; Harron DW; Meredith PA; McDevitt DG; Shanks RG
Br J Clin Pharmacol; 1985 Dec; 20(6):659-67. PubMed ID: 2868744
[TBL] [Abstract][Full Text] [Related]
9. Comparison of kinetic interactions of nadolol and propranolol with cimetidine.
Duchin KL; Stern MA; Willard DA; McKinstry DN
Am Heart J; 1984 Oct; 108(4 Pt 2):1084-6. PubMed ID: 6148867
[TBL] [Abstract][Full Text] [Related]
10. Comparative effects of adimolol, labetalol and propranolol on heart rate and blood pressure in man.
Riddell JG; Harron DW; Shanks RG
Br J Clin Pharmacol; 1985 Apr; 19(4):405-10. PubMed ID: 2859871
[TBL] [Abstract][Full Text] [Related]
11. Beta-adrenoceptor blocking effects and plasma levels of bornaprolol and propranolol in man.
Thuillez C; Richer C; Duhazé P; Bergougnan L; Giudicelli JF
Eur J Clin Pharmacol; 1985; 29(4):405-11. PubMed ID: 3912184
[TBL] [Abstract][Full Text] [Related]
12. Isoprenaline- and exercise- induced tachycardia in the assessment of beta-adrenoceptor blocking drugs; a comparison between tolamolol, practolol and propranolol.
Adam KR; Pullman LG; Scholfield PC
Br J Pharmacol; 1973 Nov; 49(3):560-3. PubMed ID: 4149697
[TBL] [Abstract][Full Text] [Related]
13. Plasma concentrations and beta-blocking effects in normal volunteers after intravenous doses of metoprolol and propranolol.
Regårdh CG; Johnsson G; Jordö L; Lungborg P; Persson BA; Rönn O
J Cardiovasc Pharmacol; 1980; 2(6):715-23. PubMed ID: 6160322
[TBL] [Abstract][Full Text] [Related]
14. Observation on the efficacy and pharmacokinetics of betaxolol (SL 75212), a cardioselective beta-adrenoceptor blocking drug.
Balnave K; Neill JD; Russell CJ; Harron DW; Leahey WJ; Wilson R; Shanks RG
Br J Clin Pharmacol; 1981 Feb; 11(2):171-80. PubMed ID: 6111331
[TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamic profile of bisoprolol, a new beta 1-selective adrenoceptor antagonist.
Leopold G; Ungethüm W; Pabst J; Simane Z; Bühring KU; Wiemann H
Br J Clin Pharmacol; 1986 Sep; 22(3):293-300. PubMed ID: 2876722
[TBL] [Abstract][Full Text] [Related]
16. Selective and non-selective beta-blockade in renin release.
Lammintausta R; Syvälahti E; Iisalo E; Kanto J; Mäntylä R
Acta Pharmacol Toxicol (Copenh); 1977 Nov; 41(5):489-96. PubMed ID: 202141
[TBL] [Abstract][Full Text] [Related]
17. Comparison of bisoprolol with other beta-adrenoceptor blocking drugs.
Krämer B; Balser J; Stubbig K; Krämer G; Kübler W
J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S46-57. PubMed ID: 2439798
[TBL] [Abstract][Full Text] [Related]
18. Human pharmacokinetic and pharmacodynamic studies on the atenolo (ICI 66,082), a new cardioselective beta-adrenoceptor blocking drug.
Conway FJ; Fitzgerald JD; McAinsh J; Rowlands DJ; Simpson WT
Br J Clin Pharmacol; 1976 Apr; 3(2):267-72. PubMed ID: 973955
[TBL] [Abstract][Full Text] [Related]
19. Effects of S-596, a new beta-adrenoceptor blocking agent on the left ventricular performance of normal subjects during exercise.
Nishida K; Niki S; Furukawa K; Yamada C; Sugihara H; Katsume H; Ijichi H
Jpn Heart J; 1985 May; 26(3):437-49. PubMed ID: 2411959
[TBL] [Abstract][Full Text] [Related]
20. Metabolic profile of beta-adrenoceptor-blocking action of befunolol.
Maruyama Y; Awaji T; Inoue M; Takeo S
Arch Int Pharmacodyn Ther; 1991; 311():73-88. PubMed ID: 1686392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]